Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Delivra (Pharmaceuticals)

Delivra (Pharmaceuticals)
2007 FOUNDED
PUBLIC STATUS
11-20 EMPLOYEES
DVA STOCK SYMBOL
1 INVESTMENTS
$0.37 SHARE PRICE (As of Thursday Closing)
Description

Delivra Corp is a specialty biotechnology company. It is a developer of transdermal technologies for the delivery of pharmaceutical and natural molecules, through the skin. It manufactures and sells natural topical creams under the LivRelief, and LivSport brand. The LivRelief brand, for conditions such as joint and muscle pain, nerve pain, varicose veins, wound healing. The LivSport brand for sports performance. The company's revenues are primarily derived from a small number of customers who operate pharmacy and grocery chains, or distribute to pharmacy and grocery chains, within Canada.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
TSX
Primary Office
  • 347 Grays Road
  • Hamilton, Ontario L8E 2Z1
  • Canada

+1 (905) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Delivra (Pharmaceuticals)’s full profile, request a free trial.

Delivra (Pharmaceuticals) Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.17 - $0.46 $17.4M $0.37 -$0.05 183K 47.5M

Delivra (Pharmaceuticals) Financials Summary

In Thousands,
USD
TTM
31-Dec-2018
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 9,100 9,569 15,308 18,260
Revenue 3,897 3,897 3,477 2,831
EBITDA (1,824) (1,824) (832) (4,260)
Net Income (2,104) (2,104) (1,143) (4,487)
Total Assets 2,436 2,436 2,654 3,425
Total Debt 1,289 1,289 1,383 2,793
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Delivra (Pharmaceuticals) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Delivra (Pharmaceuticals)‘s full profile, request access.

Request full access to PitchBook

Delivra (Pharmaceuticals) Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000 000000 21-Dec-2015 000000000000000000 00.000 Other Financial Services 00000 00000000
To view this company’s complete investment and acquisition history, request access »

Delivra (Pharmaceuticals) Executive Team (5)

Name Title Board
Seat
Contact
Info
Joseph Gabriele Founder, Chairman, Chief Executive Officer & Chief Scientific Officer
Chris Schnarr Chief Financial Officer
Howard Lichtman Chief Marketing Officer
Jeff Hull Director

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »